The clinical management of inoperable endometrial carcinoma.

@article{Palisoul2016TheCM,
  title={The clinical management of inoperable endometrial carcinoma.},
  author={Marguerite L Palisoul and David G. Mutch},
  journal={Expert review of anticancer therapy},
  year={2016},
  volume={16 5},
  pages={515-21}
}
Unresectable endometrial cancer, while rare, has a very poor prognosis, with a survival rate of 2 to 8 months. Although endometrial cancer is generally regarded as a survivable disease, the less common advanced and aggressive forms account for a large portion of endometrial cancer related deaths. Given the paucity of inoperable disease, randomized clinical… CONTINUE READING